164 related articles for article (PubMed ID: 31235410)
41. Serum alpha-fetoprotein measurement in predicting clinical outcome related to autologous cytokine-induced killer cells in patients with hepatocellular carcinoma undergone minimally invasive therapy.
Pan CC; Huang ZL; Li W; Zhao M; Zhou QM; Xia JC; Wu PH
Chin J Cancer; 2010 Jun; 29(6):596-602. PubMed ID: 20507732
[TBL] [Abstract][Full Text] [Related]
42. [Chemoembolization in hepatocellular carcinoma: multivariate analysis of survival prognostic factors after the first session].
El Khaddari S; Gaudin JL; Abidi H; Picaud G; Rode A; Souquet JC
Gastroenterol Clin Biol; 2002; 26(8-9):728-34. PubMed ID: 12434077
[TBL] [Abstract][Full Text] [Related]
43. Outcomes of patients with elevated α-fetoprotein level and initial negative findings at MR imaging.
Kim BS; Hayashi PH; Kim SH; Angthong W; Srirattanapong S; Woosley JT; Semelka RC
Radiology; 2013 Jul; 268(1):109-19. PubMed ID: 23392426
[TBL] [Abstract][Full Text] [Related]
44. Predictive Factors for Complete Response and Recurrence after Transarterial Chemoembolization in Hepatocellular Carcinoma.
Jeong SO; Kim EB; Jeong SW; Jang JY; Lee SH; Kim SG; Cha SW; Kim YS; Cho YD; Kim HS; Kim BS; Kim YJ; Goo DE; Park SY
Gut Liver; 2017 May; 11(3):409-416. PubMed ID: 28208001
[TBL] [Abstract][Full Text] [Related]
45. Image quality of arterial phase and parenchymal blood volume (PBV) maps derived from C-arm computed tomography in the evaluation of transarterial chemoembolization.
Zitzelsberger T; Syha R; Grözinger G; Partovi S; Nikolaou K; Grosse U
Cancer Imaging; 2018 May; 18(1):16. PubMed ID: 29720249
[TBL] [Abstract][Full Text] [Related]
46. Dual-phase Cone-beam CT-based Navigation Imaging Significantly Enhances Tumor Detectability and Aids Superselective Transarterial Chemoembolization of Liver Cancer.
Yao X; Yan D; Jiang X; Li X; Zeng H; Liu D; Li H
Acad Radiol; 2018 Aug; 25(8):1031-1037. PubMed ID: 29398432
[TBL] [Abstract][Full Text] [Related]
47. Alpha-fetoprotein response after locoregional therapy for hepatocellular carcinoma: oncologic marker of radiologic response, progression, and survival.
Riaz A; Ryu RK; Kulik LM; Mulcahy MF; Lewandowski RJ; Minocha J; Ibrahim SM; Sato KT; Baker T; Miller FH; Newman S; Omary R; Abecassis M; Benson AB; Salem R
J Clin Oncol; 2009 Dec; 27(34):5734-42. PubMed ID: 19805671
[TBL] [Abstract][Full Text] [Related]
48. Chemoembolization of extrahepatic collateral arteries for treatment of hepatocellular carcinoma in the caudate lobe of the liver.
Woo S; Kim HC; Chung JW; Jung HS; Hur S; Lee M; Jae HJ
Cardiovasc Intervent Radiol; 2015 Apr; 38(2):389-96. PubMed ID: 24934735
[TBL] [Abstract][Full Text] [Related]
49. Effectiveness of intraprocedural dual-phase cone-beam computed tomography in detecting hepatocellular carcinoma and improving treatment outcomes following conventional transarterial chemoembolization.
Cho Y; Lee S; Park SJ
PLoS One; 2021; 16(1):e0245911. PubMed ID: 33513172
[TBL] [Abstract][Full Text] [Related]
50. Neutrophil/Lymphocyte Ratio Predicts Increased Risk of Immediate Progressive Disease following Chemoembolization of Hepatocellular Carcinoma.
Cruz JC; Watchmaker JM; Albin MM; Wang L; Wu G; Baker JC; Fritsche MR; Alexopoulos SP; Matsuoka L; Fleming JW; Su J; Borgmann AJ; Banovac F; Brown DB
J Vasc Interv Radiol; 2019 Dec; 30(12):1887-1892. PubMed ID: 31669086
[TBL] [Abstract][Full Text] [Related]
51. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
[TBL] [Abstract][Full Text] [Related]
52. Rate and Predictive Factors for Sustained Complete Response after Selective Transarterial Chemoembolization (TACE) in Patients with Hepatocellular Carcinoma.
Bannangkoon K; Hongsakul K; Tubtawee T; McNeil E; Sriplung H; Chongsuvivatwong V
Asian Pac J Cancer Prev; 2018 Dec; 19(12):3545-3550. PubMed ID: 30583681
[TBL] [Abstract][Full Text] [Related]
53. Tumor Markers AFP, AFP-L3, and DCP in Hepatocellular Carcinoma Refractory to Transcatheter Arterial Chemoembolization.
Hiraoka A; Ishimaru Y; Kawasaki H; Aibiki T; Okudaira T; Toshimori A; Kawamura T; Yamago H; Nakahara H; Suga Y; Azemoto N; Miyata H; Miyamoto Y; Ninomiya T; Hirooka M; Abe M; Matsuura B; Hiasa Y; Michitaka K
Oncology; 2015; 89(3):167-74. PubMed ID: 25999038
[TBL] [Abstract][Full Text] [Related]
54. False-negative rate of abdominal sonography for detecting hepatocellular carcinoma in patients with hepatitis B and elevated serum alpha-fetoprotein levels.
Mok TS; Yu SC; Lee C; Sung J; Leung N; Lai P; Leung TW; Chan AT; Yeo W; Koh J; Johnson P
AJR Am J Roentgenol; 2004 Aug; 183(2):453-8. PubMed ID: 15269040
[TBL] [Abstract][Full Text] [Related]
55. Nine-year experience of doxorubicin-eluting beads chemoembolization for hepatocellular carcinoma.
Cheung AH; Lam CS; Tam HS; Cheung TT; Pang R; Poon RT
Hepatobiliary Pancreat Dis Int; 2016 Oct; 15(5):493-498. PubMed ID: 27733318
[TBL] [Abstract][Full Text] [Related]
56. Radiologic monitoring of hepatocellular carcinoma tumor viability after transhepatic arterial chemoembolization: estimating the accuracy of contrast-enhanced cross-sectional imaging with histopathologic correlation.
Hunt SJ; Yu W; Weintraub J; Prince MR; Kothary N
J Vasc Interv Radiol; 2009 Jan; 20(1):30-8. PubMed ID: 19028117
[TBL] [Abstract][Full Text] [Related]
57. Ultraselective transcatheter arterial chemoembolization for small hepatocellular carcinoma guided by automated tumor-feeders detection software: technical success and short-term tumor response.
Miyayama S; Yamashiro M; Ikuno M; Okumura K; Yoshida M
Abdom Imaging; 2014 Jun; 39(3):645-56. PubMed ID: 24549881
[TBL] [Abstract][Full Text] [Related]
58. Depiction of viable tumor in hepatocellular carcinoma treated with transarterial chemoembolization: multiphasic helical CT with review of the previous serial CT images.
Jang KM; Choi D; Lim HK; Lim JH; Lee JY; Lee WJ; Kim SH; Lee SJ; Jeon YH; Lee J; Kim MJ; Shin SW; Park CK
Korean J Radiol; 2005; 6(3):153-60. PubMed ID: 16145290
[TBL] [Abstract][Full Text] [Related]
59. Evaluation of Tumor Response Using Alpha-fetoprotein and Des-gamma-carboxy Prothrombin in Hepatocellular Carcinoma Patients Who Underwent Transarterial Chemoembolization.
Cerban R; Ester C; Iacob S; Paslaru L; Dumitru R; Grasu M; Constantin G; Popescu I; Gheorghe L
Chirurgia (Bucur); 2018; 113(4):524-533. PubMed ID: 30183583
[TBL] [Abstract][Full Text] [Related]
60. Imaging guidance with C-arm CT: prospective evaluation of its impact on patient radiation exposure during transhepatic arterial chemoembolization.
Kothary N; Abdelmaksoud MH; Tognolini A; Fahrig R; Rosenberg J; Hovsepian DM; Ganguly A; Louie JD; Kuo WT; Hwang GL; Holzer A; Sze DY; Hofmann LV
J Vasc Interv Radiol; 2011 Nov; 22(11):1535-43. PubMed ID: 21875814
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
